- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04461314
Hotline Service for Drug-abusing Youth and Young Adults
MedPAC Hotline: A Medical Peer Addiction Counselling Hotline Service for Drug-abusing Youth and Young Adults
Aim: Providing peer counselling service delivered by student counsellors with a medical background via a hotline to drug-abusing youth and young adult aged 35 or below.
Objectives:
i. To raise anti-drug awareness of young people in general and identify high-risk/hidden drug-abusing youth and young adult aged 35 or below in Hong Kong; and ii. To train university students with a medical background as peer counsellors; and iii. To provide drug abuse hotline service by students with a medical background as peer counsellors to drug-abusing youth and young adult aged 35 or below, and other people who call for help, including drug abusers' family members, friends, and professionals; and iv. To improve the drug-abusing youth and young adult' knowledge about the hazard of drug abuse, negative attitude, and perception towards the drug abuse through the telephone peer counselling service provided by students with medical background; and v. To increase the intention to quit and the help-seeking behavior among the drug-abusing youth and young adult; vi. To increase reduction rate and abstinence rate from drug abuse, and decrease the relapse rate among drug-abusing youth and young adult through the telephone peer counseling service.
Study Overview
Detailed Description
The MedPAC Hotline Service will be promoted to high-risk and drug-abusing youth and young adults through a variety of platforms, namely schools and youth service organizations, industries, community, mass media and internet, social media, posters and snowball approach.
The hotline service will operate from 5 p.m. to 9 p.m. on weekday and from 2 p.m. to 8 p.m. on weekend. A peer counsellor or a research assistant will answer the telephone inquiries from 9:30 a.m. to 5 p.m. on weekdays.
About 50 university students will be trained as peer counsellors through a structured training programme. The students will be invited to complete the pre, post and 6-month self-administered questionnaire before, immediately and 6-month after the training programme to examine their changes of knowledge of and attitudes towards addiction counselling. A satisfaction survey will also be conducted to measure their perception on the quality of training programme.
Peer counsellors will use telephone-based, Peer-led Brief Motivational Interviewing (BMI) counselling to motivate and encourage drug-abusing or high-risk youth and young adults to rehabilitate from drug abuse, assist them to manage the withdrawal symptoms, and help identify barriers and facilitators to rehabilitate from drug abuse in the telephone counselling. The peer counsellors will give referral advices if the youth and young adult needs appropriated treatment and rehabilitation services.
The drug-abusing youth and young adults will be counselled and invited to complete the follow-up questionnaires over the telephone after joining the MedPAC Hotline Service programme for 1 week, 1 month, 3 months, 6 months, 9 months and 1 year. Self-reported quitters at 6-month and 1-year follow-ups were invited to have urine test to validate the drug abuse abstinence status.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Wei Xia, PhD
- Phone Number: +85239176650
- Email: xiavive@hku.hk
Study Locations
-
-
Pokfulam
-
Hong Kong, Pokfulam, Hong Kong
- Recruiting
- The University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The inclusion criteria of target service group for this quitline programme is that current drug abusers in Hong Kong who should (1) be aged 35 or below, (2) be able to communicate in Cantonese, and (3) have a history of drug abuse within the past 12 months (including all types of drugs such as narcotics analgesics, hallucinogens, depressants, stimulants, tranquillizers and other recreational drugs).
- The inclusion criteria of peer counsellors providing counselling service in this quitline programme are those who should (1) be aged 18 - 35, (2) be able to communicate in Cantonese, (3) have a medical background, (4) complete the training courses and pass the evaluation of peer counsellor qualification.
Exclusion Criteria:
- Those who are psychologically or physically unable to communicate will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Peer-led counselling
|
About 50 university students will be trained as peer counsellors through a structured training programme. A pre and post and 6-month self-administered questionnaire will be conducted before, immediately and 6-month after the training programme to examine their changes of knowledge and attitudes. A satisfaction survey will also be conducted to measure participants' perception of the quality of the training programme. Drug-abusing youth and young adults will receive telephone-based, Peer-led Brief Motivational Interviewing (BMI) counselling to rehabilitate from drug abuse. The peer counsellors will give referral advice if the youth and young adult needs appropriate treatment and rehabilitation services. The drug abusers will be counselled and invited to complete the follow-up questionnaires at 1 week, 1 month, 3 months, 6 months, 9 months and 1 year. Self-reported quitters at 6-month and 1-year follow-ups will be invited to have a urine test to validate the drug abuse abstinence. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in drug consumption at 12-month follow-up
Time Frame: Baseline and 12 months
|
Drug abuser's drug consumption is measured at 12-month follow-up.
A questionnaire asking the frequency of drug use in the past 30 days will be used for assessing the self-reported change in drug consumption.
|
Baseline and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
30 days self-reported drug abstinence at 6-month and 12-month follow-up
Time Frame: Baseline, 6 months and 12 months
|
Self-reported drug abstinence (do not use drug for at least 30 days during the time of follow-up) at 6-month and 12-month.
A questionnaire asking the drug use status, quitting experience will be used for assessing the self-reported drug abstinence.
|
Baseline, 6 months and 12 months
|
|
Change in drug consumption at 6-month follow-up
Time Frame: Baseline and 6 months
|
Drug abuser's drug consumption is measured at 6-month follow-up.
A questionnaire asking the frequency of drug use in the past 30 days will br used for assessing the self-reported change in drug consumption.
|
Baseline and 6 months
|
|
Change in relapse risk among the quitters
Time Frame: Baseline and 12 months
|
Drug quitter's relapse risk is measured at 12-month follow-up.
A questionnaire using Stimulant Relapse Risk Scale (SRRS) with the questions of the intention to use drugs, compulsivity for drugs and impetus and confidence to avoid drugs etc. will be used for assessing the relapse risk at 12-month follow-up.
The higher the scores, the higher the relapse risk.
|
Baseline and 12 months
|
|
Change of the contemplation stage
Time Frame: Baseline, 6 months and 12 months
|
Drug abuser's change of the contemplation stage at 6-month and 12-month follow-up.
A questionnaire asking the intention to quit drug abuse and experience of drug abstinence to match the stage in contemplation ladder will be used for assessing the contemplation stage at 6-month and 12-month.
|
Baseline, 6 months and 12 months
|
|
Changes of the perceived treatment needs and motivation towards solving the problem of drug abuse
Time Frame: Baseline, 6 months and 12 months
|
Drug abuser's change of perceived treatment needs and motivation towards solving the problem among drug abusers at 6-month and 12-month.
A questionnaire using the Treatment Needs/Motivation Scales (TCU MOTForm) will be used for assessing the level of the intention and motivation to receive treatment of solving the drug abuse problem.
The higher the scores, the higher the perceived treatment needs and motivation.
|
Baseline, 6 months and 12 months
|
|
Change of self-efficacy of drug abusers to avoid drug use
Time Frame: Baseline, 6 months and 12 months
|
Drug abuser's change of self-efficacy to avoid drug use at 6-month and 12-month follow-up.
The Adolescent Relapse Coping Questionnaire (ARCQ) will be used for evaluating the self-efficacy to avoid drug use.
It comprises 6 questions for a given condition about drug temptation.
The higher the score, the higher the self-efficacy of drug abusers to avoid drug use.
|
Baseline, 6 months and 12 months
|
|
Drug abuser's improvement of knowledge and attitude on drug abuse hazards
Time Frame: Baseline, 6 months and 12 months
|
Drug abuser's improvement of knowledge and attitude on drug abuse hazards at 6-month and 12-month follow-up.
A questionnaire asking about the knowledge and attitude on drug abuse with a scale called "knowledge and attitude on drug abuse for drug abuser" will be used for assessing the change of knowledge and attitude on drug abuse.
The higher the scores, the better the knowledge and attitude.
|
Baseline, 6 months and 12 months
|
|
Peer counsellor's improvement of knowledge and attitude on drug abuse hazards
Time Frame: Baseline, immediately after the training programme and 6 months
|
Peer counsellor's improvement of knowledge and attitude on drug abuse hazards immediately after the training programme and after 6 months will be measured by a scale called "knowledge and attitude on drug abuse for peer counsellor" in a self-reporting structured questionnaire.
The higher the scores, the better the knowledge and attitude.
|
Baseline, immediately after the training programme and 6 months
|
|
Satisfaction of peer counsellors to the drug abuse training programme
Time Frame: Immediately after the training programme
|
Satisfaction of peer counsellors to the drug abuse training programme will be collected.
A questionnaire asking about the comments of content, practicability, speakers from the peer counsellors with the satisfaction scale will be used for evaluating the satisfaction immediately after the training programme.
The higher the scores, the greater the satisfaction of the training programme.
|
Immediately after the training programme
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MedPAC Hotline
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug Abuse
-
Lund UniversityCompletedIntravenous Drug Abuse, S Aureus Colonization
-
Duke UniversityCompletedHealth Behavior | Opioid Use, Unspecified | Benzodiazepine Abuse | Prescription Drug Abuse (Not Dependent) | Benzodiazepine Dependent | Prescription Drug Abuse and DependencyUnited States
-
Stuart WillickSports Medicine Research and Testing Laboratory; Partnership for Clean CompetitionCompletedSports Drug Abuse | Abuse of Steroids or HormonesUnited States
-
Eli Lilly and CompanyCompletedPrescription Drug Abuse (Not Dependent) | Recreational Drug UseUnited States
-
INSYS Therapeutics IncCompletedDrug Abuse, MedicationCanada
-
University of Colorado, DenverCompletedMedication AbuseUnited States
-
Boston UniversityNational Institute on Drug Abuse (NIDA)WithdrawnIntravenous Drug Abuse
-
The Hong Kong Polytechnic UniversityRecruiting
-
National Institute on Drug Abuse (NIDA)Completed
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)Completed
Clinical Trials on peer-led counselling
-
The University of Hong KongHealth and Medical Research FundCompleted
-
University of PittsburghUniversity of Pittsburgh Medical CenterTerminatedAdolescent Behavior | E-Cig UseUnited States
-
Gia Dinh People HospitalNot yet recruitingAnticoagulants; Circulating, Hemorrhagic Disorder
-
International Centre for Diarrhoeal Disease Research...University of SydneyCompletedCognitive Change | Infant Malnutrition
-
US Department of Veterans AffairsMedical College of Wisconsin; Disabled American Veterans; The American Legion... and other collaboratorsCompleted
-
University of Eastern FinlandSocial Insurance Institution, Finland; Finnish Cultural FoundationRecruiting
-
The University of Hong KongActive, not recruiting
-
Rutgers, The State University of New JerseyMerck Sharp & Dohme LLC; Thomas Jefferson UniversityCompletedInfectious Disease | Pneumonia, Bacterial | Influenza | Zoster; HerpesUnited States
-
Bahirdar UniversityNot yet recruiting